[Lecture Report] “Policy Discourse on Disease-Modifying Drugs for Dementia and Past Developments” (The 66th Annual Meeting of the Japan Geriatrics Society, Symposium 12: New Trends in Integrated Dementia Care After the Launch of Disease-Modifying Drugs; June 14, 2024; Nagoya City, Aichi Prefecture)
date : 6/24/2024
Tags: Dementia
Mr. Shunichiro Kurita Senior Manager at Health and Global Policy Institute (HGPI) and Ms. Akari Hase, Program Specialist, gave a lecture titled “Policy Discourse on Disease-Modifying Drugs for Dementia and Past Developments” at the 66th Annual Meeting of the Japan Geriatrics Society. The lecture was given during Symposium 12: New Trends in Integrated Dementia Care After the Launch of Disease-Modifying Drugs. During the lecture, Mr. Kurita shared examples demonstrating how policy discourse has changed in Japan and overseas after the recent launch of disease-modifying drugs for dementia. He also shared an analysis on the effects that specialized knowledge in this field has on policy formulation.
Top Research & Recommendations Posts
Featured Posts
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)
-
2026-11-05
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 7: Where We’ve Been and Where We’re Going: Lessons from Pandemic Response” (December 18, 2026)
-
2026-11-13
[Discussion Points] Addressing AMR Measures for an Era of Healthy Longevity: Ensuring Safety and Security for Older Adults in a Super-Aged Society (October 23, 2026)



